Renal Interstitial Distribution of Full‐Length IgG and Fab Fragments in Unilateral Ureteral Obstruction‐Induced Fibrotic Kidneys
Biopharmaceutics & Drug Disposition · 2025
DOI: 10.1002/bdd.70004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biopharmaceutics & Drug Disposition, 2025. Verfasst von Yuki Nakamura und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Division of Clinical Pharmacy, Graduate School of Pharmaceutical Science, Hokkaido University of Science, Sapporo, Japan. Hauptthemen laut MEDLINE: Ureteral Obstruction, Immunoglobulin Fab Fragments, Immunoglobulin G, Kidney. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Pharmaceutical Society of Japan.
Abstract (Originalsprache)
Renal fibrosis, a critical contributor to chronic kidney disease, is characterized by interstitial expansion and excessive extracellular matrix accumulation. Due to their specificity, monoclonal antibodies (mAbs) and their fragments are promising candidates for treating renal fibrosis, but their distribution characteristics in fibrotic kidneys, particularly within the renal interstitium, remain unclear. This study investigated the tissue distribution of full‐length IgG and Fab fragments in a unilateral ureteral obstruction (UUO)‐induced renal fibrosis mouse model. Full‐length IgG and Fab fragments were intravenously administered in UUO‐induced renal fibrosis model mice. The concentrations in each organ and plasma were quantified using enzyme‐linked immunoassay. In addition, the localization within the renal interstitium was evaluated by multiple techniques, including intravital and ex vivo confocal imaging under near‐living conditions and the observation of the tissue sections via an in vivo cryotechnique. Both full‐length IgG and Fab fragments showed higher distribution in fibrotic kidneys than in other organs. Specifically, Fab fragments had excellent selective accumulation in the fibrotic kidneys, whereas full‐length IgG had higher absolute distribution due to slower plasma elimination. Imaging assessments revealed that both had widespread localization within the interstitial spaces of the fibrotic kidneys. Due to their superior selectivity for fibrotic kidneys, Fab fragments can be used to target fibrotic lesions. Due to its prolonged distribution, full‐length IgG may offer advantages in sustained therapeutic effects. This study provides foundational insights into the distribution of mAbs and their fragments in fibrotic kidneys and underscores the importance of further pharmacokinetic analyses to refine antibody‐based therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Division of Clinical Pharmacy, Graduate School of Pharmaceutical Science, Hokkaido University of Science, Sapporo, Japan.
- Creation Research Institute of Life Science in KITA-no-DAICHI, Sapporo, Japan.
ORCID-Profile: Yuki Nakamura, Kohei Togami, Sumio Chono
Förderung
- Japan Society for the Promotion of Science
- Pharmaceutical Society of Japan
Zitieren
APA
Nakamura, Y., Togami, K., & Chono, S. (2025). Renal Interstitial Distribution of Full‐Length IgG and Fab Fragments in Unilateral Ureteral Obstruction‐Induced Fibrotic Kidneys. Biopharmaceutics & Drug Disposition. https://doi.org/10.1002/bdd.70004
Vancouver
Nakamura Y, Togami K, Chono S. Renal Interstitial Distribution of Full‐Length IgG and Fab Fragments in Unilateral Ureteral Obstruction‐Induced Fibrotic Kidneys. Biopharmaceutics & Drug Disposition. 2025. doi:10.1002/bdd.70004
BibTeX
@article{Nakamura2025,
author = {Nakamura, Yuki and Togami, Kohei and Chono, Sumio},
title = {Renal Interstitial Distribution of Full‐Length IgG and Fab Fragments in Unilateral Ureteral Obstruction‐Induced Fibrotic Kidneys},
journal = {Biopharmaceutics & Drug Disposition},
year = {2025},
doi = {10.1002/bdd.70004}
}
EUVIMED